Medications

FDA skeptical of benefits from experimental ALS drug

Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.

Neuroscience

Experimental gene therapy targets Duchenne muscular dystrophy

Children in Rochester were recently among the first in the nation to receive an experimental treatment for Duchenne muscular dystrophy (DMD). The study is part of an accelerating trend of clinical trials involving gene therapies ...

Health

Clinician peer networks remove race and gender bias

A University of Pennsylvania study published today in Nature Communications offers striking evidence that network science can be used to remove race and gender bias in clinical settings. The study, led by Professor Damon ...

page 1 from 11